WallStreetZenWallStreetZen

NASDAQ: INMB
Inmune Bio Inc Earnings & Revenue

INMB past revenue growth

How has INMB's revenue growth performed historically?
Company
-58.56%
Industry
165.61%
Market
17.84%
INMB's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
INMB's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance

INMB earnings and revenue history

Current Revenue
$155.0k
Current Earnings
-$30.0M
Current Profit Margin
-19,360%

INMB Return on Equity

Current Company
-64.1%
Current Industry
-63.6%
Current Market
188%
INMB's Return on Equity (-64.1%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when INMB announces earnings.

INMB Return on Assets

Current Company
-45.6%
Current Industry
3%
INMB is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

INMB Return on Capital Employed

Current Company
-77.87%
Current Industry
19.6%
INMB's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

INMB vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
INMB$155.00k-$30.01M-$30.01M+235.68%N/A
CAPR$25.18M-$21.22M-$22.29M+72.02%N/A
ZVRA$16.56M-$38.67M-$39.92M+9.64%N/A
MACK$0.00-$1.17M-$1.18MN/AN/A
ATNM$0.00-$49.39M-$50.14M-100.00%N/A

INMB earnings dates

Next earnings date
May 1, 2024

Inmune Bio Earnings & Revenue FAQ

What were INMB's earnings last quarter?

On Invalid Date, Inmune Bio (NASDAQ: INMB) reported Q4 2023 earnings per share (EPS) of -$0.47, up 46.88% year over year. Total Inmune Bio earnings for the quarter were -$8.41 million. In the same quarter last year, Inmune Bio's earnings per share (EPS) was -$0.32.

If you're new to stock investing, here's how to buy Inmune Bio stock.

What was INMB's earnings growth in the past year?

As of Q1 2024, Inmune Bio's earnings has grown year over year. Inmune Bio's earnings in the past year totalled -$30.01 million.

What is INMB's earnings date?

Inmune Bio's earnings date is Invalid Date. Add INMB to your watchlist to be reminded of INMB's next earnings announcement.

What was INMB's revenue last quarter?

On Invalid Date, Inmune Bio (NASDAQ: INMB) reported Q4 2023 revenue of $28.00 thousand up 71.13% year over year. In the same quarter last year, Inmune Bio's revenue was $97.00 thousand.

What was INMB's revenue growth in the past year?

As of Q1 2024, Inmune Bio's revenue has grown -58.56% year over year. This is 224.17 percentage points lower than the US Biotechnology industry revenue growth rate of 165.61%. Inmune Bio's revenue in the past year totalled $155.00 thousand.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.